top of page
Valeda PBM is the first and only FDA-authorized treatment for dry AMD to improve and maintain vision for up to 2 years
Retina Specialists of Minnesota is the first retina specialist in Minnesota to offer Valeda treatment to patients with dry AMD.
Valeda PBM LIGHTSITE III clinical trial met the predetermined primary efficacy endpoint at Month 21
84% of Valeda PBM–treated patients improved or maintained vision at ~2 years compared to baseline
More than 60% of Valeda PBM–treated patients experienced ≥1-line vision improvement at about 2 years compared to baseline
Just 3 Treatments each week for
3 weeks!
Treatments can fit into your daily life.
Treatments are given here at the office with Dr. Montezuma. It may take up to 10 minutes or less to complete.
​
​
Valeda PBM is non-invasive, which means there are no needles; only light us used.
​
Your pupils are not dilated, and there is no anesthesia. This means you are free to carry on with your daily activities after treatment.
​
​
LIGHTSITE IIIB Extends PBM Evidence in Dry AMD
https://www.retinalphysician.com/issues/2025/julyaugust/asrs15/
bottom of page